American Society of Nephrology
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$94,403,827
Investments
79%
Other Assets
10%
Cash & Equivalents
7%
Property, Plant, & Equipment (net)
3%
Receivables (Non-Related)
<1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$20,858,209
Other Liabilities
64%
Notes Payable / Debt (Non-Related)
16%
Deferred Revenue
10%
Payables & Accruals
10%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,487,168
$6,769,119
+355%
Receivables (Non-Related)
$606,944
$624,475
+3%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$473,073
$448,479
-5%
Investments
$74,269,594
$74,943,263
+1%
Property, Plant, & Equipment (net)
$2,855,149
$2,502,882
-12%
Other Assets
$10,611,681
$9,115,609
-14%
Total Assets
$90,303,609
$94,403,827
+5%
Liabilities
2023
2024
Change
Payables & Accruals
$3,188,253
$2,043,149
-36%
Grants Payable
-
-
-
Deferred Revenue
$1,333,026
$2,071,360
+55%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
$3,400,000
-
Related-Party Payables
-
-
-
Other Liabilities
$15,341,425
$13,343,700
-13%
Total Liabilities
$19,862,704
$20,858,209
+5%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$70,440,905
$73,545,618
+4%
Net assets
2023
2024
Change
Net assets
+$70,440,905
+$73,545,618
+4%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)